THE INVESTOR

메뉴열기
April 26, 2024

14 offenders fined W2.4b for illegal trading of Hanmi Pharm stocks

PUBLISHED : May 24, 2017 - 17:22

UPDATED : May 24, 2017 - 18:18

  • 본문폰트 작게
  • 본문폰트 크게
  • 페이스북
  • sms

[THE INVESTOR] The South Korean financial regulator has fined 14 individuals a combined 2.4 billion won (US$2.1 million) for using undisclosed information to reap illegal profits through stock trading of Hanmi Pharmaceutical, a leading local drug firm, in September last year. 

The Financial Services Commission said its securities & futures commission made the decision on May 24 to impose a massive fine on individuals for disrupting market order. It is the largest fine to be imposed on an individual that reaches as high as 1.34 billion won, since it first enacted the related regulation in July, 2015. The highest fine so far had been around 39 million imposed in a different case in December.




The FSC’s move is a follow-up measure after Seoul prosecutors had found in December that the 45 offenders, including Hanmi employees, had engaged in strategic stock transactions to reap illegal profits worth 3.3 billion won based on knowledge of undisclosed information about a deal’s collapse between Hanmi and Germany’s Boehringer Ingelheim.

Out of the 45, the prosecution had asked the FSC to investigate 25, who avoided indictment as second, third, fourth and fifth information receivers.

Among the 25, 11 were exempt from the fine, the FSC said.

The insider information about the broken deal started spreading from an employee at Hanmi and the first receiver relayed the information to another individual investor. While the employee and the first receiver were indicted by the prosecution, the second to fifth information receivers were fined 4.6 million won, 210 million won, 381 million won and 1.34 billion won, respectively, the FSC said.

The undisclosed information also spread through school and hometown connections as well as families, it said.

On Sept. 30, Hanmi Pharm disclosed at 9:29 a.m. that its deal with Boehringer Ingelheim was broken. Its shares plunged after the annoucement in massive short selling.

Short selling refers to a technique in which an investor borrows shares and immediately sells them, anticipating that the price will drop so he or she can buy them back at a lower price. 

By Kim Yoon-mi/The Korea Herald (yoonmi@heraldcorp.com)

  • 페이스북
  • sms
최상단으로
COPYRIGHT HERALD CORPORATION. ALL RIGHTS RESERVED.